Evaluation of the Efficacy and Safety of Absorbable vs Traditional Bone Wax for Facet Fusion After Lumbar Fusion Surgery

Exclusion Criteria

• •Individuals with a hemorrhagic predisposition or coagulation disorders, indicated by a prothrombin time (PT) of 18 seconds or greater, and those with a history of prolonged anticoagulant use.
• •Individuals presenting with lumbar spine infections or fractures.
• •Individuals with known allergies to materials such as polyethylene glycol, sodium carboxymethyl cellulose, and bone wax (including beeswax, paraffin, and isopropyl palmitate).
• •Individuals whose conditions are critical, making it challenging to accurately assess the efficacy and safety of the equipment.
• •Individuals deemed by researchers to have poor compliance, rendering them unable to fulfill the study requirements.
• •Women who are currently pregnant, intend to become pregnant within the past year, or are breastfeeding.
• •Individuals who have participated in other clinical trials within the preceding 30 days to prevent cross-interference.
• •Individuals with significant complications or comorbidities, such as severe cardiovascular, hepatic, renal, or other chronic conditions that could influence surgical risks and research outcomes.
• •Individuals identified by researchers as having a life expectancy of less than six months.
• •Individuals with severe osteoporosis, defined as a bone mineral density T-score of ≤-2.5 accompanied by fragility fractures.
• •Any other individuals deemed unsuitable for participation in this clinical trial by the researchers.